Edwards Lifesciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell EW and other ETFs, options, and stocks.

About EW

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care.

CEO

Bernard J. Zovighian

CEOBernard J. Zovighian

Employees

16,000

Employees16,000

Headquarters

Irvine, California

HeadquartersIrvine, California

Founded

1958

Founded1958

Employees

16,000

Employees16,000

EW Key Statistics

Market cap

47.58B

Market cap47.58B

Price-Earnings ratio

47.72

Price-Earnings ratio47.72

Dividend yield

—

Dividend yield—

Average volume

5.91M

Average volume5.91M

High today

$90.00

High today$90.00

Low today

$82.40

Low today$82.40

Open price

$87.90

Open price$87.90

Volume

10.47M

Volume10.47M

52 Week high

$96.29

52 Week high$96.29

52 Week low

$72.30

52 Week low$72.30

Stock Snapshot

Edwards Lifesciences(EW) stock is priced at $82.63, giving the company a market capitalization of 47.58B. It carries a P/E multiple of 47.72.

On 2026-07-25, Edwards Lifesciences(EW) stock moved within a range of $82.40 to $90.00. With shares now at $82.63, the stock is trading +0.3% above its intraday low and -8.2% below the session's peak.

Trading volume for Edwards Lifesciences(EW) stock has reached 10.47M, versus its average volume of 5.91M.

The stock's 52-week range extends from a low of $72.30 to a high of $96.29.

EW News

TipRanks 8h

Edwards Lifesciences Lifts Outlook On TAVR And TMTT

Edwards Lifesciences Corp. ((EW)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful investing t...

Investing.com 18h

Bernstein raises Edwards Lifesciences stock price target on earnings beat - Investing.com

...

TipRanks 19h

Edwards Lifesciences price target raised to $105 from $100 at JPMorgan

JPMorgan raised the firm’s price target on Edwards Lifesciences (EW) to $105 from $100 and keeps an Overweight rating on the shares. Unlock powerful investing...

Analyst ratings

77%

of 30 ratings

Buy

76.7%

Hold

23.3%

Sell

More EW News

Benzinga 23h

Stock Market Today: S&P 500, Dow Jones Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus

U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday’s lower close. However, Brent Crude Futures...

Nasdaq 1d

Edwards Lifesciences Q2 Profit Down; Raises 2026 Sales Outlook

(RTTNews) - Edwards Lifesciences Corp. (EW) on Thursday reported a lower profit in the second quarter, as revenues increased 14%. Net income declined to $241.9...

Nasdaq 2d

Edwards Lifesciences Q2 26 Earnings Conference Call At 5:00 PM ET

(RTTNews) - Edwards Lifesciences Corp. (EW) will host a conference call at 5:00 PM ET on July 23, 2026, to discuss Q2 26 earnings results. To access the live w...

Simply Wall St 7d

Edwards Lifesciences Faces FTC Penalty, Is The Stock Still Cheap?

Advertisement Regulatory shock puts Edwards Lifesciences stock under a sharper lens The Federal Trade Commission’s record $12 million penalty tied to Edwards...

People also own

Based on the portfolios of people who own EW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.